The clinical pharmacology of methotrexate.
暂无分享,去创建一个
[1] J. Grant. Reversed Rotation of the Intestine with Encapsulating Peritonitis* , 1940, British medical journal.
[2] J. Wolff,et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. , 1948, The New England journal of medicine.
[3] R D SULLIVAN,et al. Antimetabolite‐metabolite combination cancer chemotherapy. Effects of intra‐arterial methotrexate—intramuscular citrovorum factor therapy in human cancer , 1959, Cancer.
[4] W. C. Werkheiser. Specific Binding of 4-Amino Folic Acid Analogues by Folic Acid Reductase , 1961 .
[5] G. A. Fischer. Detective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. , 1962, Biochemical pharmacology.
[6] E. Henderson,et al. The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man. , 1965, Cancer research.
[7] I. Djerassi,et al. Long-Term Remissions in Childhood Acute Leukemia , 1966 .
[8] S. Farber,et al. Continuous infusion of methotrexate in children with acute leukemia , 1967, Cancer.
[9] D. Williams,et al. A colorimetric assay system for tetrahydrofolate dehydrogenase. , 1968, Biochemical pharmacology.
[10] T. Hall,et al. Triamterene-induced elevation of dihydrofolate reductase activity in human leukocytes. , 1968, Biochemical pharmacology.
[11] D. Hutchison,et al. On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia. , 1968, Cancer research.
[12] V. Oliverio,et al. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. , 1968, The Journal of biological chemistry.
[13] E. Henderson,et al. The effect of organic acids on renal clearance of methotrexate in man , 1969, Clinical pharmacology and therapeutics.
[14] S. Comaish,et al. Site of action of methotrexate in psoriasis. , 1969, Archives of dermatology.
[15] J. Bertino,et al. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue". , 1970, Cancer research.
[16] P. Ernst,et al. Perturbation of generation cycle of human leukemic myeloblasts in vivo by methotrexate. , 1971, Blood.
[17] I. Goldman. THE CHARACTERISTICS OF THE MEMBRANE TRANSPORT OF AMETHOPTERIN AND THE NATURALLY OCCURRING FOLATES , 1971, Annals of the New York Academy of Sciences.
[18] V. Oliverio,et al. Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid. , 1972, Biochemical pharmacology.
[19] J. Bertino,et al. Enzymatic Cleavage of Methotrexate provides a Method for Prevention of Drug Toxicity , 1972, Nature.
[20] A. V. Hoffbrand,et al. Unbalanced Deoxyribonucleotide Synthesis Caused by Methotrexate , 1972, British medical journal.
[21] I. Goldman,et al. Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells. , 1973, The Journal of biological chemistry.
[22] R. Jackson,et al. Studies with a mathematical model of folate metabolism. , 1973, Archives of biochemistry and biophysics.
[23] B. Chabner,et al. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. , 1973, The Journal of clinical investigation.
[24] J. Bertino,et al. Improved therapeutic index of methotrexate with "leucovorin rescue". , 1973, Cancer research.
[25] B. Hoogstraten,et al. Effect of route of administration and effusions on methotrexate pharmacokinetics. , 1974, Cancer research.
[26] R. Cailleau,et al. Tissue culture studies on pleural effusions from breast carcinoma patients. , 1974, Cancer research.
[27] F. M. Huennekens,et al. Effects of sulfhydryl inhibitors upon transport of folate compounds into L1210 cells. , 1974, Biochemical pharmacology.
[28] Goldman Id. The Mechanism of Action of Methotrexate: I. Interaction with a Low-Affinity Intracellular Site Required for Maximum Inhibition of Deoxyribonucleic Acid Synthesis in L-Cell Mouse Fibroblasts , 1974 .
[29] B. Hoogstraten,et al. Pharmacokinetics of methotrexate , 1973, Clinical pharmacology and therapeutics.
[30] H. Weiss,et al. Neurotoxicity of commonly used antineoplastic agents (first of two parts). , 1974, The New England journal of medicine.
[31] N. Jaffe,et al. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. , 1974, The New England journal of medicine.
[32] N. Jaffe. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors. , 1974, Cancer chemotherapy reports.
[33] I. Goldman. Analysis of the cytotoxic determinants for methotrexate (NSC 740): a role for 'free' intracellular drug , 1975 .
[34] M. Berman,et al. Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man. , 1975, Cancer chemotherapy reports.
[35] P. Schein,et al. Immunosuppressive and cytotoxic chemotherapy: long-term complications. , 1975, Annals of internal medicine.
[36] S. Waxman,et al. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis. , 1975, Cancer research.
[37] R. Capizzi. SCHEDULE-DEPENDENT SYNERGISM AND ANTAGONISM BETWEEN METHOTREXATE AND ASPARAGINASE* , 1975 .
[38] W. Shapiro,et al. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. , 1975, The New England journal of medicine.
[39] R. Moran,et al. Effects of allopurinol on the therapeutic efficacy of methotrexate. , 1975, Cancer research.
[40] J. White,et al. The mechanism of action of methotrexate. III. Requirement of free intracellular methotrexate for maximal suppression of (14C)formate incorporation into nucleic acids and protein. , 1975, Molecular pharmacology.
[41] E. Frei,et al. The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects , 1975, Nature.
[42] C. N. Coleman,et al. The clinical pharmacology of antineoplastic agents (second of two parts). , 1975, The New England journal of medicine.
[43] C. N. Coleman,et al. The Clinical Pharmacology of Antineoplastic Agents , 1975 .
[44] Martin H. Cohen,et al. Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients , 1976, Cancer.
[45] C. Putman,et al. METHOTREXATE-INDUCED PNEUMONITIS , 1976, Medicine.
[46] B. Chabner,et al. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. , 1976, The Journal of clinical investigation.
[47] B. Chabner,et al. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. , 1976, Cancer research.
[48] H. Mouridsen,et al. The pharmacokinetics of cyclophosphamide in man following treatment with methotrexate. , 2009, Acta pharmacologica et toxicologica.
[49] S. Jacobs,et al. Accumulation of methotrexate diglutamate in human liver during methotrexate therapy. , 1977, Biochemical pharmacology.
[50] J. Bull,et al. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion. , 1977, Cancer research.
[51] G. Browman,et al. Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines. , 1977, Chemico-biological interactions.
[52] D. Rosenthal,et al. High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement. , 1977, Blood.
[53] B. Chabner,et al. Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. , 1977, Cancer treatment reports.
[54] D. Zaharko,et al. Relative biochemical aspects of low and high doses of methotrexate in mice. , 1977, Cancer research.
[55] S. Rosenberg,et al. Methotrexate and hemodialysis. , 1977, Annals of internal medicine.
[56] Antifolates: in vivo kinetic considerations. , 1977 .
[57] Effects of methotrexate on cellular metabolism: Some critical elements in the drug cell interaction , 1977 .
[58] W. Ensminger,et al. The prevention of methotrexate toxicity by thymidine infusions in humans. , 1977, Cancer research.
[59] A. Freeman,et al. High-dose methotrexate in acute lymphocytic leukemia. , 1977, Cancer treatment reports.
[60] J. Rasey,et al. The effect of photon irradiation on blood‐brain barrier permeability to methotrexate in mice , 1977, Cancer.
[61] D. Talbot,et al. Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues. , 1977, Journal of the National Cancer Institute.
[62] S. Rosenberg,et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. , 1977, The New England journal of medicine.
[63] B. Chabner,et al. Dose-dependent metabolism of methotrexate in man and rhesus monkeys. , 1977, Cancer treatment reports.
[64] Bondy Pk,et al. Some observations on the human pharmacology of methotrexate. , 1977 .
[65] G. Weinstein. Drugs Five Years Later: Methotrexate , 1977 .
[66] Frei E rd,et al. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. , 1977 .
[67] V. Whitehead. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells. , 1977, Cancer research.
[68] Antimetabolites in the central nervous system. , 1977 .
[69] W. Strum. A pH-dependent, carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum. , 1977, The Journal of pharmacology and experimental therapeutics.
[70] D. Rosenblatt,et al. Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells. , 1978, Molecular pharmacology.
[71] S. Howell,et al. Hemodialysis and enzymatic cleavage of methotrexate in man. , 1978, European journal of cancer.
[72] S. Howell,et al. Thymidine rescue of high-dose methotrexate in humans. , 1978, Cancer research.
[73] C. Pratt,et al. Effect of pleural effusion on high‐dose methotrexate kinetics , 1978, Clinical pharmacology and therapeutics.
[74] R. Benjamin,et al. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate , 1978, British medical journal.
[75] R. Donehower,et al. Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells. , 1978, Cancer research.
[76] A. Goldin. Studies with high-dose methotrexate--historical background. , 1978, Cancer treatment reports.
[77] G. Grindey,et al. Potentiation of the antitumor activity of methotrexate by concurrent infusion of thymidine. , 1978, Cancer research.
[78] Jacobsen Sa,et al. Phase I trial of high-dose methotrexate with modified citrovorum factor rescue. , 1978 .
[79] H. Kaplan,et al. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue. , 1979, Cancer research.
[80] L. Irwin,et al. Anaphylactic reaction to high-dose methotrexate. , 1979, Cancer treatment reports.
[81] J. White,et al. Formation of methotrexate polyglutamates in rat hepatocytes. , 1979, Cancer research.
[82] A. Nyfors,et al. Cytogenetic effects of methotrexate on human cells in vivo: comparison between results obtained by chromosome studies on bone-marrow cells and blood lymphocytes and by the micronucleus test. , 1979, Mutation research.
[83] S. Hilliard,et al. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells. , 1979, Cancer research.
[84] R. Donehower,et al. Presence of 2,4‐diamino‐N10‐methylpteroic acid after high‐dose methotrexate , 1979, Clinical pharmacology and therapeutics.
[85] J. White,et al. Characteristics of transport of 4-amino antifolates and folate compounds by two lines of L5178Y lymphoblasts, one with impaired transport of methotrexate. , 1979, Cancer research.
[86] F. Sirotnak,et al. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia. , 1979, Cancer treatment reports.
[87] C. Heidelberger,et al. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[88] S. Howell,et al. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate. , 1979, Cancer research.
[89] W. M. Shehata,et al. The enhancement effect of irradiation by methotrexate. Report of three complications , 1980, Cancer.
[90] R. Schimke. Gene amplification and drug resistance. , 1980, Scientific American.
[91] J. Goldie,et al. A methotrexate insensitive variant of folate reductase present in two lines of methotrexate-resistant L5178Y cells. , 1980, European journal of cancer.
[92] J. White,et al. Effects of 2,4-dinitrophenol and other metabolic inhibitors on the bidirectional carrier fluxes, net transport, and intracellular binding of methotrexate in Ehrlich ascites tumor cells. , 1980, Cancer research.
[93] S. Waxman,et al. Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductase. , 1980, European journal of cancer.
[94] M. Wick,et al. Natural resistance to methotrexate in human melanomas. , 1980, The Journal of investigative dermatology.
[95] C. R. Pinkerton,et al. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia. , 1980, British Journal of Cancer.
[96] Effect of gentamicin and irradiation on the toxicity of high-dose methotrexate in rats. , 1980 .
[97] R. Bast,et al. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. , 1980, The American journal of medicine.
[98] W. Flintoff,et al. Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. , 1980, Biochemistry.
[99] C. R. Pinkerton,et al. CAN FOOD INFLUENCE THE ABSORPTION OF METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKÆMIA? , 1980, The Lancet.
[100] J. Mulder,et al. Cell kinetic factors, single drugs and combination. , 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[101] J. Lankelma,et al. Change in Transfer Rate of Methotrexate from Spinal Fluid to Plasma during Intrathecal Therapy in Children and Adults , 1980, Clinical pharmacokinetics.
[102] H. Pinedo,et al. Effect of methotrexate on 5-phosphoribosyl 1-pyrophosphate levels in L1210 leukemia cells in vitro. , 1980, Cancer research.
[103] J. Galivan. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate. , 1980, Molecular pharmacology.
[104] S. Howell,et al. Achievement of long duration methotrexate exposure with concurrent low dose thymidine protection: influence of methotrexate pharmacokinetics. , 1980, European journal of cancer.
[105] R. Schilsky,et al. Methotrexate polyglutamate synthesis by cultured human breast cancer cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[106] J. Lankelma,et al. The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy. , 1980, Cancer letters.
[107] F. M. Huennekens,et al. Inhibition of dihydrofolate reductase by methotrexate: a new look at an old problem. , 1980, Advances in enzyme regulation.
[108] W. Flintoff,et al. Selection of wild-type revertants from methotrexate-resistant cells containing an altered dihydrofolate reductase , 1980, Somatic cell genetics.
[109] J R Bertino,et al. 5-fluorouracil-methotrexate synergy: enhancement of 5-fluorodeoxyridylate binding to thymidylate synthase by dihydropteroylpolyglutamates. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[110] S. Howell,et al. Thymidine requirements for the rescue of patients treated with high-dose methotrexate. , 1980, Cancer research.
[111] F. Sirotnak,et al. Extracellular recovery of methotrexate-polyglutamates following efflux from L1210 leukemia cells. , 1980, Biochemical pharmacology.
[112] C. R. Pinkerton,et al. Enterotoxic effect of methotrexate: does it influence the drug's absorption in children with acute lymphoblastic leukaemia? , 1981, British medical journal.
[113] S. Howell,et al. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. , 1981, Journal of the National Cancer Institute.
[114] V. Devita,et al. High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer. , 1981, Cancer research.
[115] R. Weichselbaum,et al. Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate‐leucovorin in patients with advanced squamous carcinoma of the head and neck: A safe new effective regimen , 1981, Cancer.
[116] D. Rosenblatt,et al. Inhibition of methotrexate polyglutamate accumulation in cultured human cells. , 1981, Molecular pharmacology.
[117] A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer , 1981, Cancer.
[118] J. Galivan. 5-Methyltetrahydrofolate transport by hepatoma cells and methotrexate-resistant sublines in culture. , 1981, Cancer research.
[119] A. Craft,et al. Methotrexate absorption in children with acute lymphoblastic leukemia. , 1981, Cancer treatment reports.
[120] E. Frenkel,et al. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption. , 1981, Annals of internal medicine.
[121] F. Sirotnak,et al. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. , 1981, Cancer research.
[122] H. Moss,et al. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. , 1981, The American journal of medicine.
[123] I. Taylor,et al. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. , 1981, Cancer research.
[124] S. Howell,et al. Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. , 1981, The Journal of clinical investigation.
[125] F. Sirotnak,et al. Differential synthesis of methotrexate polyglutamates in normal proliferative and neoplastic mouse tissues in vivo. , 1981, Cancer research.
[126] R. Schilsky,et al. High-pressure liquid chromatography analysis of methotrexate polyglutamates in cultured human breast cancer cells. , 1981, Biochemical pharmacology.
[127] J. Mulder,et al. 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling. , 1981, European journal of cancer & clinical oncology.
[128] R. Donehower,et al. Competitive protein binding assay of methotrexate. , 1975, Methods in enzymology.